|
About the bayes category
|
|
0
|
2638
|
July 21, 2018
|
|
Should one derive risk difference from the odds ratio?
|
|
618
|
47185
|
August 16, 2023
|
|
How to infer the analysts' priors from this figure?
|
|
6
|
747
|
February 22, 2023
|
|
First approach to the rmsb package - issues
|
|
44
|
13091
|
January 20, 2023
|
|
Discrepancies between the rmsb package and RStan
|
|
2
|
664
|
September 29, 2022
|
|
Rmsb: Relative Explained Variation of Clustering Variable
|
|
8
|
1738
|
September 7, 2022
|
|
Bayesian vs. Frequentist Statements About Treatment Efficacy
|
|
0
|
911
|
September 4, 2022
|
|
A Bayes-Frequentist approach to the Analysis of Credibility of meta-analyses using p-values
|
|
10
|
2900
|
October 11, 2021
|
|
How to model an outcome measure bounded between 0 and 100 using Bayesian analysis
|
|
9
|
2957
|
September 22, 2021
|
|
Prior distributions for observational studies - Is it worth it?
|
|
6
|
2027
|
September 9, 2021
|
|
Multiplicity Adjustments in Bayesian Analysis
|
|
22
|
12454
|
August 29, 2021
|
|
Discussion: Why Bayes for Clinical Trials
|
|
7
|
5132
|
August 12, 2021
|
|
How to replace p-value on Bayes statistics?
|
|
2
|
1806
|
July 27, 2021
|
|
Frequentist vs Bayesian debate applied to real-world data analysis: any philosophical insights?
|
|
10
|
9040
|
April 6, 2021
|
|
What would get Stan more use in FDA IND applications?
|
|
14
|
4443
|
November 18, 2020
|
|
Bayesian Solutions for Challenges to Frequentist Statistics
|
|
0
|
4933
|
September 22, 2020
|
|
Empirical Bayes for RCT Interpretarion
|
|
8
|
4951
|
August 11, 2020
|
|
Who should define reasonable priors and how?
|
|
15
|
13422
|
May 29, 2020
|
|
Conditional Independence Assumption
|
|
2
|
3916
|
September 30, 2019
|
|
Choice of Bayesian priors in an observational study
|
|
11
|
5055
|
September 5, 2019
|
|
Bayesian approach to diagnostic validity?
|
|
3
|
4287
|
January 25, 2019
|
|
Interim Analysis & "Alpha Spending" in RCT's using Bayesian Analyses
|
|
15
|
6780
|
January 25, 2019
|